Circulating MicroRNA-188, -30a, and -30e as Early Biomarkers for Contrast-Induced Acute Kidney Injury
Shi-Qun Sun, Tuo Zhang, Ding Ding, Wei-Feng Zhang, Xiao-Lei Wang, Zhe Sun, Liu-Hua Hu, Sheng-Ying Qin, Ling-Hong Shen, Ben He, Shi-Qun Sun, Tuo Zhang, Ding Ding, Wei-Feng Zhang, Xiao-Lei Wang, Zhe Sun, Liu-Hua Hu, Sheng-Ying Qin, Ling-Hong Shen, Ben He
Abstract
Background: Contrast-induced acute kidney injury (CI-AKI) is typically defined by an increase in serum creatinine after intravascular administration of contrast medium. Because creatinine is an unreliable indicator of acute changes in kidney function, we assessed whether circulating microRNAs (miRNAs) could serve as biomarkers for early detection of CI-AKI.
Methods and results: Using a rat model of CI-AKI, we first evaluated the miRNA profile of rat plasma and kidney. Three miRNA species with >1.5-fold increase in plasma samples of CI-AKI rats, including miRNA-188, miRNA-30a, and miRNA-30e, were selected as candidate miRNAs. Quantitative real-time polymerase chain reaction showed that these candidate miRNAs peaked in concentration around 4 hours after contrast medium exposure and were relatively renal-specific. We compared the plasma levels of these candidate miRNAs in 71 patients who underwent coronary angiography or percutaneous coronary intervention and developed CI-AKI with those of 71 matched controls. The plasma levels of the 3 candidate miRNAs were significantly elevated in the CI-AKI group as compared to the control group. Receiver operating characteristic analysis showed that these miRNAs significantly distinguished patients with CI-AKI from those without CI-AKI. MiRNA composites were highly accurate for CI-AKI prediction, as shown in maximized specificity by treble-positive miRNA composite or maximized Youden index by any-positive miRNA composite. Moreover, the selected miRNAs changes were associated with Mehran Risk Scores.
Conclusions: Plasma levels of candidate miRNAs significantly distinguished patients with CI-AKI from those without CI-AKI. Thus, miRNAs are potential biomarkers for early detection of CI-AKI.
Keywords: biomarker; contrast‐induced nephropathy; microRNA.
© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Figures
References
- McCullough PA. Contrast‐induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419–1428.
- Nash K, Hafeez A, Hou S. Hospital‐acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936.
- Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Genereux P, Nikolsky E, Brener SJ, Witzenbichler B, Guagliumi G, Clark AE, Fahy M, Xu K, Brodie BR, Stone GW. Contrast‐induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS‐AMI substudy. Eur Heart J. 2014;35:1533–1540.
- Lameire N, Van Biesen W, Vanholder R. Acute kidney injury. Lancet. 2008;372:1863–1865.
- Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Almen T, Aspelin P, Bellin MF, Clement O, Heinz‐Peer G. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–2541.
- Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta‐analysis. Am J Kidney Dis. 2002;40:221–226.
- Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73:1008–1016.
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
- Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122:6–7.
- Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31:659–666.
- Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012;32:326–348.
- Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol. 2011;300:F602–F610.
- Sun S, Zhang T, Nie P, Hu L, Yu Y, Cui M, Cai Z, Shen L, He B. A novel rat model of contrast‐induced acute kidney injury. Int J Cardiol. 2014;172:e48–e50.
- Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A. Cystatin C and contrast‐induced acute kidney injury. Circulation. 2010;121:2117–2122.
- Foundation NK . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
- Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast‐induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399.
- Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription‐PCR (qRT‐PCR). Methods. 2010;50:298–301.
- Schmittgen TD, Livak KJ. Analyzing real‐time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
- Efron B. The bootstrap and modern statistics. J Am Stat Assoc. 2000;95:1293–1296.
- Zhang W, Carriquiry A, Nettleton D, Dekkers JC. Pooling mRNA in microarray experiments and its effect on power. Bioinformatics. 2007;23:1217–1224.
- Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166.
- Gutierrez‐Escolano A, Santacruz‐Vazquez E, Gomez‐Perez F. Dysregulated microRNAs involved in contrast‐induced acute kidney injury in rat and human. Ren Fail. 2015;37:1498–1506.
- Wu J, Lv Q, He J, Zhang H, Mei X, Cui K, Huang N, Xie W, Xu N, Zhang Y. MicroRNA‐188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes. Cell Commun Signal. 2014;12:66.
- Quintavalle C, Brenca M, De Micco F, Fiore D, Romano S, Romano MF, Apone F, Bianco A, Zabatta MA, Troncone G, Briguori C, Condorelli G. In vivo and in vitro assessment of pathways involved in contrast media‐induced renal cells apoptosis. Cell Death Dis. 2011;2:e155.
- Agrawal R, Tran U, Wessely O. The miR‐30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development. 2009;136:3927–3936.
- Rickli H, Benou K, Ammann P, Fehr T, Brunner‐La Rocca HP, Petridis H, Riesen W, Wuthrich RP. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004;61:98–102.
- Wi J, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y. Prediction of contrast‐induced nephropathy with persistent renal dysfunction and adverse long‐term outcomes in patients with acute myocardial infarction using the Mehran Risk Score. Clin Cardiol. 2012;36:46–53.
- Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium‐induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008;300:1038–1046.
Source: PubMed